Yale University, Department of Psychiatry publishes research in alcoholism therapy

Data detailed in "Naltrexone and disulfiram in patients with alcohol dependence and current depression" have been presented. According to recent research from the United States, "Although disulfiram and naltrexone have been approved by the Food and Drug Administration for the treatment of alcoholism, no medications have been approved for individuals with alcohol dependence and comorbid psychiatric disorders. In particular, the effect of these medications on alcohol use outcomes and on specific psychiatric symptoms is still unknown in patients with the most common co-occurring disorder, major depression. Two hundred fifty-four patients with a major Axis I psychiatric disorder and comorbid...

Want to see the full article?

• Purchase this article for only $3.00